Attitudes of Dutch intensive care unit clinicians towards oxygen therapy.


Journal

The Netherlands journal of medicine
ISSN: 1872-9061
Titre abrégé: Neth J Med
Pays: Netherlands
ID NLM: 0356133

Informations de publication

Date de publication:
07 2020
Historique:
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 3 6 2021
Statut: ppublish

Résumé

Over the last decade, there has been an increasing awareness for the potential harm of the administration of too much oxygen. We aimed to describe self-reported attitudes towards oxygen therapy by clinicians from a large representative sample of intensive care units (ICUs) in the Netherlands. In April 2019, 36 ICUs in the Netherlands were approached and asked to send out a questionnaire (59 questions) to their nursing and medical staff (ICU clinicians) eliciting self-reported behaviour and attitudes towards oxygen therapy in general and in specific ICU case scenarios. In total, 1361 ICU clinicians (71% nurses, 24% physicians) from 28 ICUs returned the questionnaire. Of responding ICU clinicians, 64% considered oxygen-induced lung injury to be a major concern. The majority of respondents considered a partial pressure of oxygen (PaO2) of 6-10 kPa (45-75 mmHg) and an arterial saturation (SaO2) of 85-90% as acceptable for 15 minutes, and a PaO2 7-10 kPa (53-75 mmHg) and SaO2 90-95% as acceptable for 24-48 hours in an acute respiratory distress syndrome (ARDS) patient. In most case scenarios, respondents reported not to change the fraction of inspired oxygen (FiO2) if SaO2 was 90-95% or PaO2 was 12 kPa (90 mmHg). A representative sample of ICU clinicians from the Netherlands were concerned about oxygen-induced lung injury, and reported that they preferred PaO2 and SaO2 targets in the lower physiological range and would adjust ventilation settings accordingly.

Sections du résumé

BACKGROUND
Over the last decade, there has been an increasing awareness for the potential harm of the administration of too much oxygen. We aimed to describe self-reported attitudes towards oxygen therapy by clinicians from a large representative sample of intensive care units (ICUs) in the Netherlands.
METHODS
In April 2019, 36 ICUs in the Netherlands were approached and asked to send out a questionnaire (59 questions) to their nursing and medical staff (ICU clinicians) eliciting self-reported behaviour and attitudes towards oxygen therapy in general and in specific ICU case scenarios.
RESULTS
In total, 1361 ICU clinicians (71% nurses, 24% physicians) from 28 ICUs returned the questionnaire. Of responding ICU clinicians, 64% considered oxygen-induced lung injury to be a major concern. The majority of respondents considered a partial pressure of oxygen (PaO2) of 6-10 kPa (45-75 mmHg) and an arterial saturation (SaO2) of 85-90% as acceptable for 15 minutes, and a PaO2 7-10 kPa (53-75 mmHg) and SaO2 90-95% as acceptable for 24-48 hours in an acute respiratory distress syndrome (ARDS) patient. In most case scenarios, respondents reported not to change the fraction of inspired oxygen (FiO2) if SaO2 was 90-95% or PaO2 was 12 kPa (90 mmHg).
CONCLUSION
A representative sample of ICU clinicians from the Netherlands were concerned about oxygen-induced lung injury, and reported that they preferred PaO2 and SaO2 targets in the lower physiological range and would adjust ventilation settings accordingly.

Identifiants

pubmed: 32641541

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-174

Auteurs

C C A Grim (CCA)

Leiden University Medical Centre, Leiden, the Netherlands.

A D Cornet (AD)

Leiden University Medical Centre, Leiden, the Netherlands.

A Kroner (A)

Leiden University Medical Centre, Leiden, the Netherlands.

A J Meiners (AJ)

Leiden University Medical Centre, Leiden, the Netherlands.

A J B W Brouwers (AJBW)

Leiden University Medical Centre, Leiden, the Netherlands.

A C Reidinga (AC)

Leiden University Medical Centre, Leiden, the Netherlands.

D J van Westerloo (DJ)

Leiden University Medical Centre, Leiden, the Netherlands.

D C J J Bergmans (DCJJ)

Leiden University Medical Centre, Leiden, the Netherlands.

D Gommers (D)

Leiden University Medical Centre, Leiden, the Netherlands.

D Versluis (D)

Leiden University Medical Centre, Leiden, the Netherlands.

D Weller (D)

Leiden University Medical Centre, Leiden, the Netherlands.

E Christiaan Boerma (E)

Leiden University Medical Centre, Leiden, the Netherlands.

E van Driel (E)

Leiden University Medical Centre, Leiden, the Netherlands.

E de Jonge (E)

Leiden University Medical Centre, Leiden, the Netherlands.

F J Schoonderbeek (FJ)

Leiden University Medical Centre, Leiden, the Netherlands.

H J F Helmerhorst (HJF)

Leiden University Medical Centre, Leiden, the Netherlands.

H G Jongsma-van Netten (HG)

Leiden University Medical Centre, Leiden, the Netherlands.

J Weenink (J)

Leiden University Medical Centre, Leiden, the Netherlands.

K J Woittiez (KJ)

Leiden University Medical Centre, Leiden, the Netherlands.

K S Simons (KS)

Leiden University Medical Centre, Leiden, the Netherlands.

L van Ewelie (L)

Leiden University Medical Centre, Leiden, the Netherlands.

M Petjak (M)

Leiden University Medical Centre, Leiden, the Netherlands.

M J Sigtermans (MJ)

Leiden University Medical Centre, Leiden, the Netherlands.

M van der Woude (M)

Leiden University Medical Centre, Leiden, the Netherlands.

O L Cremer (OL)

Leiden University Medical Centre, Leiden, the Netherlands.

P Bijlstra (P)

Leiden University Medical Centre, Leiden, the Netherlands.

P van der Heiden (P)

Leiden University Medical Centre, Leiden, the Netherlands.

R K L So (RKL)

Leiden University Medical Centre, Leiden, the Netherlands.

R Vink (R)

Leiden University Medical Centre, Leiden, the Netherlands.

T Jansen (T)

Leiden University Medical Centre, Leiden, the Netherlands.

W de Ruijter (W)

Leiden University Medical Centre, Leiden, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH